Latest News in the pharma Industry

Market News

Optibrium and MolPort collaborate to improve speed and cost-efficiency of drug discovery

Optibrium and MolPort collaborate to improve speed and cost-efficiency of drug discovery

30 Nov 2016

Partnership combines MolPort’s 6.3 Million HTS Compounds with StarDrop’s data analysis and compound design capabilities.

Read more 
The CellSeal Automated Thawing System solves a vital aspect of cell-based therapy development

The CellSeal Automated Thawing System solves a vital aspect of cell-based therapy development

30 Nov 2016

Enables detailed control in thawing of cell and gene therapies.

Read more 
Re-usable capmats offer increased chemical resistance

Re-usable capmats offer increased chemical resistance

29 Nov 2016

The silicone capmats reseal after each piercing and may be re-pierced many times without loss of function.

Read more 
Thousands could benefit from greater use of revolutionary stroke treatment

Thousands could benefit from greater use of revolutionary stroke treatment

29 Nov 2016

Mechanical thrombectomy is a more effective treatment than clot-busting drugs alone for acute stroke caused by blockage of a large blood vessel by a clot.

Read more 
Patheon to acquire state-of-the-art manufacturing site

Patheon to acquire state-of-the-art manufacturing site

29 Nov 2016

Company gains additional API capacity and major supply agreement with Roche

Read more 
Catalent boosts its global OTC and prescription softgel capabilities and capacity

Catalent boosts its global OTC and prescription softgel capabilities and capacity

28 Nov 2016

Company acquires two state-of-the-art facilities offering integrated softgel development, manufacturing and packaging.

Read more 
New software platform to control the cryogenic cold chain for cellular therapies

New software platform to control the cryogenic cold chain for cellular therapies

28 Nov 2016

Enables standardization and audit of remote freezing and thawing.

Read more 
Mylan agrees to produce and market generic version of BMS's Daklimza in developing countries

Mylan agrees to produce and market generic version of BMS's Daklimza in developing countries

28 Nov 2016

The license allows Mylan to develop fixed-dose combinations that offer the potential to treat all of the six major genotypes of hepatitis C virus.

Read more 
IL-17 inhibitors will drive psoriatic arthritis market to $12.6 billion by 2025

IL-17 inhibitors will drive psoriatic arthritis market to $12.6 billion by 2025

27 Nov 2016

The increase in diagnosed prevalent cases and the launches of interleukin (IL)-17 inhibitors, such as Eli Lilly’s Taltz and AstraZeneca’s Lumicef, will drive the market.

Read more 
Indian pharma companies forecast 30% growth in 2017 at CPhI India

Indian pharma companies forecast 30% growth in 2017 at CPhI India

24 Nov 2016

Domestic sales identified as chief driver behind unexpected rise in revenues.

Read more 
Non-small cell lung cancer market to gain over $20 billion in value by 2025

Non-small cell lung cancer market to gain over $20 billion in value by 2025

24 Nov 2016

It's anticipated that 65% of the total NSCLC market will go to immuno-oncology therapies.

Read more 
European Commission approves BMS's Opdivo for Hodgkin's

European Commission approves BMS's Opdivo for Hodgkin's

24 Nov 2016

Opdivo is now the first and only PD-1 inhibitor approved for a hematologic malignancy in the European Union.

Read more